Does SATRALIZUMAB-MWGE Cause Optic neuritis? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Optic neuritis have been filed in association with SATRALIZUMAB-MWGE. This represents 1.5% of all adverse event reports for SATRALIZUMAB-MWGE.
17
Reports of Optic neuritis with SATRALIZUMAB-MWGE
1.5%
of all SATRALIZUMAB-MWGE reports
0
Deaths
8
Hospitalizations
How Dangerous Is Optic neuritis From SATRALIZUMAB-MWGE?
Of the 17 reports, 8 (47.1%) required hospitalization.
Is Optic neuritis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SATRALIZUMAB-MWGE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does SATRALIZUMAB-MWGE Cause?
Neuromyelitis optica spectrum disorder (181)
Off label use (87)
Urinary tract infection (87)
Pneumonia (64)
Covid-19 (47)
No adverse event (47)
Fatigue (41)
Headache (36)
Pain (36)
Arthralgia (31)
What Other Drugs Cause Optic neuritis?
FINGOLIMOD (619)
INTERFERON BETA-1A (422)
DIMETHYL (373)
NATALIZUMAB (272)
OCRELIZUMAB (236)
ADALIMUMAB (229)
TERIFLUNOMIDE (225)
GLATIRAMER (196)
OFATUMUMAB (185)
RITUXIMAB (164)
Which SATRALIZUMAB-MWGE Alternatives Have Lower Optic neuritis Risk?
SATRALIZUMAB-MWGE vs SAXAGLIPTIN
SATRALIZUMAB-MWGE vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SATRALIZUMAB-MWGE vs SCOPOLAMINE
SATRALIZUMAB-MWGE vs SCOPOLAMINE HYDROBROMIDE
SATRALIZUMAB-MWGE vs SEBELIPASE ALFA